Another one added to my ignore list - sorry but if there is no substance ever in your thoughts, well, put simply for those more simple one's; 'Time is money' - Why waste reading someone's posts when you get absolutely nothing out of it.
An impatient trader has somewhat been defined as either two things:
1) A trader that has a bad strike rate and one who continually gets burnt by bad investments, or,
2) More of a gambler than a trader
Do not be gambling in this environment because it would be straight up suicide.
Lease renewal must be close but if not I can wait. The longer it takes the more exciting it becomes - LOL.
Cheerio Nikess.
- Forums
- ASX - By Stock
- website
Another one added to my ignore list - sorry but if there is no...
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
FWD
Queensland's housing crisis an opportunity for ASX builder Fleetwood – and taxpayer cash a safe harbour from the storm
SKS
SKS Technologies wins US$90M award to supply power to international hyperscale data centre in Melbourne
Add MLS (ASX) to my watchlist
|
|||||
Last
2.0¢ |
Change
0.001(5.26%) |
Mkt cap ! $14.51M |
Open | High | Low | Value | Volume |
2.0¢ | 2.0¢ | 2.0¢ | $2.496K | 124.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
7 | 946687 | 1.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.0¢ | 29215 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
7 | 946687 | 0.019 |
10 | 3760324 | 0.018 |
5 | 2479623 | 0.017 |
1 | 30000 | 0.016 |
2 | 166666 | 0.015 |
Price($) | Vol. | No. |
---|---|---|
0.020 | 29215 | 1 |
0.021 | 717061 | 4 |
0.022 | 331081 | 2 |
0.023 | 66125 | 2 |
0.025 | 704194 | 4 |
Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
Featured News
SKS
SKS Technologies wins US$90M award to supply power to international hyperscale data centre in Melbourne
TLX
Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug
MLS (ASX) Chart |